News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Basilea Pharmaceutica (BSLN.SW) Reports Presentation of 19 Posters at ICAAC on Investigational Anti-Infectives Isavuconazole, Ceftobiprole, and BAL30072


9/13/2013 9:21:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that 19 posters are being presented on the anti-infectives isavuconazole, ceftobiprole, and BAL30072 at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The conference is taking place from September 10 to 13, 2013 in Denver, USA.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES